Here, the evidence raises a separate caution: a 2024 review discussing GLP1 receptor agonists and implantation stresses uncertainty about how these drugs may affect endometrial receptivity , and a PCOS-focused review reiterates that GLP1RAs are not advised during pregnancy (while also noting limited human exposure data)
Here are some side effects reported that some people are unable to tolerate: Gastrointestinal Effects Some individuals may experience mild gastrointestinal side effects, including nausea, vomiting, or diarrhea, especially during the initial stages of treatment
Available as once-weekly injection (Ozempic/Wegovy) and daily oral tablet (Rybelsus)
Generating fusions to glutathione S-transferase for protein studies
Eat more fruits and vegetables
On April 30, 2026, the FDA proposed formally excluding semaglutide and tirzepatide from the 503B bulk drug substances list, a move that would close the last major large-scale compounding pathway for these medications if finalized